↓ Skip to main content

Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan

Overview of attention for article published in Arthritis Research & Therapy, March 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

news
3 news outlets
policy
1 policy source

Citations

dimensions_citation
31 Dimensions

Readers on

mendeley
60 Mendeley